ATE530651T1 - Leishmania antigene für verwendung in der therapie und diagnose von leishmaniose - Google Patents

Leishmania antigene für verwendung in der therapie und diagnose von leishmaniose

Info

Publication number
ATE530651T1
ATE530651T1 AT04000341T AT04000341T ATE530651T1 AT E530651 T1 ATE530651 T1 AT E530651T1 AT 04000341 T AT04000341 T AT 04000341T AT 04000341 T AT04000341 T AT 04000341T AT E530651 T1 ATE530651 T1 AT E530651T1
Authority
AT
Austria
Prior art keywords
therapy
polypeptides
leishmaniosis
diagnosis
leishmania antigens
Prior art date
Application number
AT04000341T
Other languages
English (en)
Inventor
Antonio Campos-Neto
John R Webb
Davin C Dillon
Steven G Reed
Yasir A W Skeiky
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/798,841 external-priority patent/US6709661B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Application granted granted Critical
Publication of ATE530651T1 publication Critical patent/ATE530651T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04000341T 1997-02-12 1998-02-12 Leishmania antigene für verwendung in der therapie und diagnose von leishmaniose ATE530651T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/798,841 US6709661B1 (en) 1995-09-22 1997-02-12 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US92060997A 1997-08-27 1997-08-27

Publications (1)

Publication Number Publication Date
ATE530651T1 true ATE530651T1 (de) 2011-11-15

Family

ID=44898339

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04000341T ATE530651T1 (de) 1997-02-12 1998-02-12 Leishmania antigene für verwendung in der therapie und diagnose von leishmaniose

Country Status (4)

Country Link
EP (2) EP1422238B1 (de)
AT (1) ATE530651T1 (de)
ES (1) ES2373878T3 (de)
PT (1) PT1422238E (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR202006914A1 (tr) * 2020-05-04 2021-11-22 Univ Yeditepe İmmunoprofi̇lakti̇k ve i̇mmunoterapöti̇k olarak ekstraselüler vezi̇külleri̇ni̇n lei̇shmani̇asi̇s hastaliği i̇çi̇n kullanimi
CN113337542A (zh) * 2021-06-10 2021-09-03 山西大学 高效表达利什曼原虫pepck的人复制缺陷型重组腺病毒载体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571515A (en) * 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
WO1995029239A2 (en) * 1994-04-22 1995-11-02 Corixa Corporation Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
US5834592A (en) * 1995-09-22 1998-11-10 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis

Also Published As

Publication number Publication date
EP1422238A2 (de) 2004-05-26
ES2373878T3 (es) 2012-02-09
PT1422238E (pt) 2012-02-06
EP1113073A2 (de) 2001-07-04
EP1422238A3 (de) 2004-12-15
EP1113073A3 (de) 2003-05-14
EP1422238B1 (de) 2011-10-26

Similar Documents

Publication Publication Date Title
ATE243750T1 (de) Leishmania-antigene zur anwendung in der leishmaniasis therapie und diagnose
ATE337399T1 (de) Zusammensetzungen zur immuntherapie und diagnose von tuberculosis
TR200001709T2 (tr) Yeni neisseria meningitids yüzey proteini
DE68929551D1 (de) Menschliche DNase
ATE182180T1 (de) Lamanin-ketten: diagnostische und therapeutische verwendung
DK0668350T3 (da) Melanomassocieret antigen, epitoper deraf samt vacciner mod melanom
WO1998042740A3 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
DE69940888D1 (de) Copolymer-1-verwandte polypeptide für die verwendung als molekulargewichtsmarker und zur therapie
EP0398955A4 (en) Diagnosis of retinoblastoma
BR9808509A (pt) Composições e métodos para o tratamento e diagnóstico do câncer de mama
WO2001079276A3 (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
WO1998035045A3 (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
ATE530651T1 (de) Leishmania antigene für verwendung in der therapie und diagnose von leishmaniose
DE69034218D1 (de) Impfstoff und Diagnostikum für den Schweine-Cholera-Virus
DE69835519D1 (de) Verfahren und zusammensetzungen für die diagnose und die behandlung von krankheiten, die mit eisenüberschuss oder eisenmangel assoziiert sind.
WO2002098359A3 (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
DE60120391D1 (de) Verwendung von hev-polypeptiden
ATE103070T1 (de) Methode zur detektion, inspektion und unterscheidung der seiten von geweben.
NL300254I2 (nl) Verzwakte herpesvirussen, herpesvirussen die vreemd DNA omvatten dat codeert voor een aminozuursequentie en vaccin dat het bevat
FR2550198B2 (fr) Nouvelles n-(aminomethyl-5 oxazolin-2yl-2)n'-phenylurees, leur methode de preparation et leur application therapeutique
ATE77964T1 (de) Sicherheitsspritze fuer blutmusternahme und einspritzungen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties